Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|October 1, 2001
Combination therapy may be answer for CTCL
Anaheim, Calif. - Combination therapy with biological responsemodifiers and careful and regular reassessment of refractory patients areof paramount importance in the effective treatment of cutaneous T-cell lymphoma,according to Carmela C. Vittorio, M.D.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
4
Fall Clinical 2026: The Data and Expert Advice Shaping Dermatology Practice
5